Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults. / Faurholt-Jepsen, Daniel; Friis, Henrik; Mwaniki, David L; Boit, Michael K; Kaduka, Lydia U; Tetens, Inge; Christensen, Dirk Lund.

I: P L o S One, Bind 16, Nr. 2, e0247600, 2021.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Faurholt-Jepsen, D, Friis, H, Mwaniki, DL, Boit, MK, Kaduka, LU, Tetens, I & Christensen, DL 2021, 'Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults', P L o S One, bind 16, nr. 2, e0247600. https://doi.org/10.1371/journal.pone.0247600

APA

Faurholt-Jepsen, D., Friis, H., Mwaniki, D. L., Boit, M. K., Kaduka, L. U., Tetens, I., & Christensen, D. L. (2021). Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults. P L o S One, 16(2), [e0247600]. https://doi.org/10.1371/journal.pone.0247600

Vancouver

Faurholt-Jepsen D, Friis H, Mwaniki DL, Boit MK, Kaduka LU, Tetens I o.a. Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults. P L o S One. 2021;16(2). e0247600. https://doi.org/10.1371/journal.pone.0247600

Author

Faurholt-Jepsen, Daniel ; Friis, Henrik ; Mwaniki, David L ; Boit, Michael K ; Kaduka, Lydia U ; Tetens, Inge ; Christensen, Dirk Lund. / Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults. I: P L o S One. 2021 ; Bind 16, Nr. 2.

Bibtex

@article{ecff4b85507b4fe586dc1782434ca174,
title = "Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults",
abstract = "Background: Abdominal obesity predict metabolic syndrome parameters at low levels of waist circumference (WC) in Africans. At the same time, the African lipid profile phenotype of low high-density lipoprotein (HDL) cholesterol without concomitant elevated triglyceride levels renders high triglyceride levels detrimental to cardiometabolic health unsuitable for identifying cardiometabolic risk in black African populations.Objectives: We aimed to identify simple clinical measures for cardiometabolic risk based on WC and HDL in an adult Kenyan population in order to determine which of the two predictors had the strongest impact.Methods: We used linear regression analyses to assess the association between the two exposure variables WC and HDL with cardiometabolic risk factors including ultrasound-derived visceral (VAT) and subcutaneous adipose tissue (SAT) accumulation, fasting and 2-h venous glucose, fasting insulin, fasting lipid profile, and blood pressure in adult Kenyans (n = 1 370), and a sub-population with hyperglycaemia (diabetes and pre-diabetes) (n = 196). The same analyses were performed with an interaction between WC and HDL to address potential effect modification. Ultrasound-based, semi-quantitative hepatic steatosis assessment was used as a high-risk measure of cardiometabolic disease.Results: Mean age was 38.2 (SD 10.7) (range 17-68) years, mean body mass index was 22.3 (SD 4.5) (range 13.0-44.8) kg/m2, and 57.8% were women. Cardiometabolic risk was found in the association between both WC and HDL and all outcome variables (p<0.05) except for HDL and SAT, fasting and 2-h venous glucose. Additive cardiometabolic risk (WC and HDL interaction) was found for SAT, low-density lipoprotein cholesterol, and triglycerides. No differences in the association between WC and HDL and the outcome variables were found when comparing the full study population and the hyperglycaemia sub-population. Increase in WC and HDL were both associated with hepatic steatosis (OR 1.09, p<0.001, and OR 0.46, p = 0.031, respectively).Conclusion: In adult Kenyans, increasing WC identified more cardiometabolic risk factors compared to HDL.",
author = "Daniel Faurholt-Jepsen and Henrik Friis and Mwaniki, {David L} and Boit, {Michael K} and Kaduka, {Lydia U} and Inge Tetens and Christensen, {Dirk Lund}",
note = "CURIS 2021 NEXS 081",
year = "2021",
doi = "10.1371/journal.pone.0247600",
language = "English",
volume = "16",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

RIS

TY - JOUR

T1 - Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adults

AU - Faurholt-Jepsen, Daniel

AU - Friis, Henrik

AU - Mwaniki, David L

AU - Boit, Michael K

AU - Kaduka, Lydia U

AU - Tetens, Inge

AU - Christensen, Dirk Lund

N1 - CURIS 2021 NEXS 081

PY - 2021

Y1 - 2021

N2 - Background: Abdominal obesity predict metabolic syndrome parameters at low levels of waist circumference (WC) in Africans. At the same time, the African lipid profile phenotype of low high-density lipoprotein (HDL) cholesterol without concomitant elevated triglyceride levels renders high triglyceride levels detrimental to cardiometabolic health unsuitable for identifying cardiometabolic risk in black African populations.Objectives: We aimed to identify simple clinical measures for cardiometabolic risk based on WC and HDL in an adult Kenyan population in order to determine which of the two predictors had the strongest impact.Methods: We used linear regression analyses to assess the association between the two exposure variables WC and HDL with cardiometabolic risk factors including ultrasound-derived visceral (VAT) and subcutaneous adipose tissue (SAT) accumulation, fasting and 2-h venous glucose, fasting insulin, fasting lipid profile, and blood pressure in adult Kenyans (n = 1 370), and a sub-population with hyperglycaemia (diabetes and pre-diabetes) (n = 196). The same analyses were performed with an interaction between WC and HDL to address potential effect modification. Ultrasound-based, semi-quantitative hepatic steatosis assessment was used as a high-risk measure of cardiometabolic disease.Results: Mean age was 38.2 (SD 10.7) (range 17-68) years, mean body mass index was 22.3 (SD 4.5) (range 13.0-44.8) kg/m2, and 57.8% were women. Cardiometabolic risk was found in the association between both WC and HDL and all outcome variables (p<0.05) except for HDL and SAT, fasting and 2-h venous glucose. Additive cardiometabolic risk (WC and HDL interaction) was found for SAT, low-density lipoprotein cholesterol, and triglycerides. No differences in the association between WC and HDL and the outcome variables were found when comparing the full study population and the hyperglycaemia sub-population. Increase in WC and HDL were both associated with hepatic steatosis (OR 1.09, p<0.001, and OR 0.46, p = 0.031, respectively).Conclusion: In adult Kenyans, increasing WC identified more cardiometabolic risk factors compared to HDL.

AB - Background: Abdominal obesity predict metabolic syndrome parameters at low levels of waist circumference (WC) in Africans. At the same time, the African lipid profile phenotype of low high-density lipoprotein (HDL) cholesterol without concomitant elevated triglyceride levels renders high triglyceride levels detrimental to cardiometabolic health unsuitable for identifying cardiometabolic risk in black African populations.Objectives: We aimed to identify simple clinical measures for cardiometabolic risk based on WC and HDL in an adult Kenyan population in order to determine which of the two predictors had the strongest impact.Methods: We used linear regression analyses to assess the association between the two exposure variables WC and HDL with cardiometabolic risk factors including ultrasound-derived visceral (VAT) and subcutaneous adipose tissue (SAT) accumulation, fasting and 2-h venous glucose, fasting insulin, fasting lipid profile, and blood pressure in adult Kenyans (n = 1 370), and a sub-population with hyperglycaemia (diabetes and pre-diabetes) (n = 196). The same analyses were performed with an interaction between WC and HDL to address potential effect modification. Ultrasound-based, semi-quantitative hepatic steatosis assessment was used as a high-risk measure of cardiometabolic disease.Results: Mean age was 38.2 (SD 10.7) (range 17-68) years, mean body mass index was 22.3 (SD 4.5) (range 13.0-44.8) kg/m2, and 57.8% were women. Cardiometabolic risk was found in the association between both WC and HDL and all outcome variables (p<0.05) except for HDL and SAT, fasting and 2-h venous glucose. Additive cardiometabolic risk (WC and HDL interaction) was found for SAT, low-density lipoprotein cholesterol, and triglycerides. No differences in the association between WC and HDL and the outcome variables were found when comparing the full study population and the hyperglycaemia sub-population. Increase in WC and HDL were both associated with hepatic steatosis (OR 1.09, p<0.001, and OR 0.46, p = 0.031, respectively).Conclusion: In adult Kenyans, increasing WC identified more cardiometabolic risk factors compared to HDL.

U2 - 10.1371/journal.pone.0247600

DO - 10.1371/journal.pone.0247600

M3 - Journal article

C2 - 33630976

VL - 16

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 2

M1 - e0247600

ER -

ID: 257600579